缺血性脑卒中住院患者914例临床分析(2)
第1页 |
参见附件。
[2] Hankey GJ.Longterm outcome after ischaemic stroke/transient ischaemic attack[J].Cerebrovasc Dis,2003,16(suppl 1):1419.
[3] Touze E,Varenne O,Chatellier G,et al.Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke:A systematic review and metaanalysis[J].Stroke,2005,36:27482755.
[4] Weimar C,Diener HC,Alberts MJ,et al.The essen stroke risk score predicts recurrent cardiovascular events:A validation within the reduction of atherothrombosis for continued health (REACH) registry[J].Stroke,2009,40:350354.
[5] 王伊龙,王春雪,赵性泉,等.非心房颤动缺血性卒中患者卒中复发的预测模型——Essen卒中风险评分量表[J].中国卒中杂志,2009,4(5):440442.
[6] Caprie steering committee.A randomized,blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events (caprie)[J].Lancet,1996,348:13291339.
[7] Diener HC,Ringleb PA,Savi P.Clopidogrel for the secondary prevention of stroke[J].Expert Opin Pharmacother,2005,6:755764.
[8] Rothwell PM.Prognostic models[J].Pract Neurol,2008,8:242253.
[9] Diener HC.Stroke prevention:Antiplatelet and antithrombolytic therapy[J].Neurol Clin,2000,18:343355.
作者简介:孙佳(1975—),女,主治医师,现工作于北京市隆福医院(邮编:100034);王红、宋清扬、任剑羽,工作于北京市隆福医院。
(收稿日期:20120302)
(本文编辑王雅洁)
您现在查看是摘要介绍页,详见PDF附件(1666kb)。